Latest Reports
Companion Diagnostics (CDx) Market - Regulatory Landscape Analysis, 2026-2035
Companion diagnostics (CDx) are becoming an integral component of precision medicine because they identify patients who are most likely to benefit from targeted therapies while reducing unnecessary treatment exposure. Their role extends bey...
Global Companion Diagnostics (CDx) Market - Competitive Landscape Analysis, (2026-2035)
Companion diagnostics (CDx) are becoming an essential component of precision medicine because they identify patients who are most likely to benefit from targeted therapies while reducing exposure to ineffective treatments. The market is evo...
Cardiovascular Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The cardiovascular diagnostics market comprises imaging systems, electrophysiology-based diagnostic platforms, molecular and in-vitro diagnostic technologies, and digital cardiac assessment solutions that enable the detection, characterizat...
Cardiac Biomarker Testing Market - Strategic Insights and Forecasts (2026-2035)
The Cardiac Biomarker Testing Market supports the rapid identification, risk assessment, and monitoring of cardiovascular disorders by measuring proteins released during myocardial injury or cardiac stress. The market is shifting toward hig...
Rare Disease Biomarker Testing Market - Strategic Insights and Forecasts (2026-2035)
Rare disease biomarker testing is becoming an essential component of precision medicine because early molecular identification directly influences diagnosis, treatment selection, disease monitoring, and family risk assessment. The market en...
Metabolic Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The metabolic disease diagnostics market encompasses laboratory and molecular technologies that identify inherited, acquired, and chronic metabolic disorders through biochemical, genetic, proteomic, and metabolomic analyses. The market supp...
Rare Disease Genetic Testing Market - Strategic Insights and Forecasts (2026-2035)
The global genetic testing market encompasses molecular and genomic assays that identify inherited, acquired, and somatic genetic variations for disease diagnosis, risk prediction, therapeutic selection, carrier screening, prenatal assessme...
Rare Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
Rare disease diagnostics is becoming a strategic component of precision medicine because earlier molecular confirmation is improving clinical decision-making across genetically heterogeneous disorders. Demand is increasingly shifting from s...
Prenatal Screening Market - Strategic Insights and Forecasts (2026-2035)
The global prenatal screening market encompasses laboratory-based and molecular diagnostic approaches that evaluate fetal genetic abnormalities and pregnancy-associated conditions before birth. The market includes non-invasive prenatal scre...
Prenatal Genetic Testing Market - Strategic Insights and Forecasts (2026-2035)
The global prenatal genetic testing market encompasses molecular and cytogenetic tests that evaluate fetal genetic abnormalities before birth through both screening and diagnostic approaches. The market includes non-invasive blood-based scr...
Newborn Screening Market - Strategic Insights and Forecasts (2026-2035)
The newborn screening market comprises laboratory assays, analytical instruments, reagents, software platforms, and follow-up diagnostic services that identify congenital, metabolic, endocrine, hematologic, immunologic, and sensory disorder...
Remote Patient Monitoring Market - Strategic Insights and Forecasts (2026-2031)
The Remote Patient Monitoring (RPM) market holds significant global importance, with healthcare systems rapidly moving towards connected, patient-centred care and value-based care models. RPM solutions incorporate connected medical devices,...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.